Beta Bionics Inc. (BBNX)
NASDAQ
19.16
-0.18 (-0.93%)
Delayed Data
Oct 23, 2026, 01:30 PM
Day's Range
18.8119.54
52 wk Range
8.8032.71
Financial Statements - BBNX - Beta Bionics Inc.
Revenue
100.25M▲ 53.9%
Net Income
-73.20M▼ 33.7%Net Margin -73.0%
EBITDA
-56.35M▼ 90.7%
Free Cash Flow
-56.22M▼ 8.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Sales | 100.25M | 65.12M | 11.99M | 179K |
| Cost of Goods | 44.71M | 29.23M | 5.68M | - |
| Gross Profit | 55.53M | 35.88M | 6.30M | 179K |
 Operating Expense | - | - | - | - |
| Operating Income | -71.68M | -45.25M | -35.85M | -65.84M |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | -12.45M | -13.41M | -10.02M | 911K |
| Pre Tax Income | -73.20M | -54.75M | -44.09M | -64.75M |
| Income Tax | - | - | - | - |
| Net Income | -73.20M | -54.75M | -44.09M | -64.75M |
| EPS Basic | -1.81 | -1.277574 | -1.446086 | -2.123302 |
| EPS Diluted | -1.81 | -1.277574 | -1.446086 | -2.123302 |
| Basic Shares Outstanding | 40.52M | 42.85M | 30.49M | 30.49M |
| Diluted Shares Outstanding | 40.52M | 42.85M | 30.49M | 30.49M |
| Ebit | -71.68M | -45.25M | -35.85M | -64.73M |
| Ebitda | -56.35M | -29.55M | -23.80M | -63.56M |
| Net Income Continuous Operations | -73.20M | -54.75M | -44.09M | -64.75M |
| Minority Interests | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
